论文部分内容阅读
美国自2010年6月25日起要求所有的营养保健品企业都必须遵守美国食品与药品管理局(FDA)的动态药品生产管理规范(cGMP)规则。并规定每个生产商必须用“适当的实验设施进行任何有必要的测试和检查以确定:a)所用成分是否符合规定;b)过程规范是否遵守主要生产记录里的规定;c)膳食添加剂生产符合要求。”这就意味着生产企业需采取措施确保产品不受有害微生物污染。
Since June 25, 2010, the United States has requested that all nutraceutical companies must comply with the FDA’s (cGMP) Code of Conduct. And stipulates that each manufacturer must perform any necessary tests and inspections at the appropriate experimental facility to determine: a) whether the ingredients used comply with the requirements; b) whether the process specification complies with the requirements set forth in the Master Production Record; c) dietary supplements Production meets the requirements. "This means that manufacturers need to take steps to ensure that products are not contaminated with harmful microorganisms.